VBIO
NASD Valion Bio, Inc.$1.16 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.16, $0.04 below the day’s high of $1.20
- YTD change
- -95.41%
- vs 20-day SMA
- -49.59%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.15 (+14.85%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 98.5% away from all-time highs of $75.50
- VBIO is down 95% since the beginning of the year
- VBIO is down 95% over the past 12 months
- VBIO is down 45% over the past 1 month
- 4% of all VBIO investors are betting against VBIO
VBIO reads poor: the 12-month move is +14.9%.
- Previous minute
- +$0.00
- Last hour
- -$0.03
- Last 5 days
- -45.79%
- vs 8-day SMA
- -31.86%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Valion Bio, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in San Antonio, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.